Business
PainTEQ Scales Leadership: Med-Tech Catalyst Robert Kline Joins Board to Drive New Standard in Interventional Spine Care
Med-tech veteran Robert Kline has joined the Board of Directors at PainTEQ, a strategic move to capitalize on his commercialization and growth expertise as the company redefines interventional spine care.
About this update from Sartorius Ag
[{"type":"text","content":"TAMPA, Fla., Oct. 28, 2025 /PRNewswire/ -- Med-tech veteran Robert Kline has joined the Board of Directors at PainTEQ, a strategic move to capitalize on his commercialization and growth expertise as the company redefines interventional spine care. ","length":247,"tagName":"p"},{"type":"image","alt":"Robert Kline, Board Member, PainTEQ","displaySize":"","headline":null,"caption":"Robert Kline, Board Member, PainTEQ","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":366,"url":"https://media.zenfs.com/en/prnewswire.com/259f0e88e73333764e07133bc36ae12f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oxP45HGxJRyVWnHaGNGv6Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTY0NTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/259f0e88e73333764e07133bc36ae12f","width":400,"height":366}},"href":"https://mma.prnewswire.com/media/2806846/Robert_Kline_Board_Member_PainTEQ.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Building on a 25-year history of commercializing groundbreaking medical devices, Kline will now focus on propelling PainTEQ's expansion and further establishing the company's market leadership. His background includes:","length":226,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Founder of Medivance, a pioneer in therapeutic temperature management, acquired by C. R. Bard (now Becton Dickinson) in 2011.","length":125,"tagName":"p"}]},{"val":[{"type":"text","content":"Co-founder of ViroCyt, a technology firm acquired by Sartorius AG in 2016.","length":74,"tagName":"p"}]},{"val":[{"type":"text","content":"Former CEO of Bolder Surgical, acquired by Hologic, Inc. for $160 million in 2021.","length":82,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":281,"olType":false},{"type":"text","content":"Following a growth recapitalization, the addition of Kline's strategic guidance strongly positions PainTEQ to accelerate the expansion and adoption of its LinQ system. Kline brings a unique synergy, rooted in his proven history at Bolder Surgical of commercializing minimally invasive solutions that significantly reduce the need for high-risk, complex surgeries.","length":367,"tagName":"p"},{"type":"text","content":""PainTEQ has a clear and essential vision for the market," said Robert Kline. "My decision to join the PainTEQ ...